Company profile: IQVIA
1.1 - Company Overview
Company description
- Provider of creative solutions for healthcare companies, including clinical development support for pharmaceuticals and medical devices leveraging global and local insights; real-world data consulting; pharmacovigilance services; market data solutions; management consulting with data analytics and M&A support; and technology solutions spanning drug development to commercialization.
Products and services
- Real World Data Consulting: Combines domestic and international real-world data to deliver comprehensive, data-driven consulting for clinical and commercial value across Japan and global markets
- Clinical Development: Architects enterprise-scale support for pharmaceutical and medical device development by integrating global knowledge with local insights to accelerate precision and speed
- Technology Solutions: Delivers modular technology systems that enhance productivity and innovation in life sciences, from drug development to commercialization
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to IQVIA
Hivebench
HQ: France
Website
- Description: Provider of a hosted digital laboratory notebook tool to manage protocols and experiments, helping researchers prepare.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hivebench company profile →
Code Ocean
HQ: United States
Website
- Description: Provider of a computational research platform enabling reproducible, data-heavy science, offering Compute Capsules that bundle code, data, and environments for traceability; cloud Pipelines for building and deploying scalable workflows with automated environment and compute management; and a Lineage Graph tracking provenance, integrating with Git and supporting role-based access control.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Code Ocean company profile →
Enterome
HQ: France
Website
- Description: Provider of clinical-stage immunomodulatory drugs for cancer and immune diseases, offering OncoMimics, a cancer immunotherapy using bacterial peptides to mimic tumor antigens, with Phase 2 candidates EO2401 (glioblastoma/adrenal), EO2463 (indolent NHL) and EO4010 (third-line colorectal), and EndoMimics oral bioactives for inflammatory/autoimmune diseases, including EB1010 for food allergies and IBD.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enterome company profile →
Clinerion
HQ: Switzerland
Website
- Description: Provider of real-world data solutions analyzing live electronic health record data from a global network of partner hospitals to accelerate clinical research and access to treatments. Offerings include Patient Network Explorer for clinical research, trial optimization, and analytics; Feasibility Insights for site feasibility and trial planning; and RWD RADAR delivering aggregated de-identified data for epidemiology, treatment metrics, and market insights.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clinerion company profile →
Eureka Genomics
HQ: United States
Website
- Description: Provider of Next Generation Sequencing and gene annotation services and diagnostics to detect inherited genetic traits, cancers, and infectious diseases in humans, animals, and crops. Offerings include detection of foreign nucleic acids, sequence data analysis, resequencing and mapping, platform-agnostic genotyping of SNPs, InDels, CNV, methylation, barley and bovine SNP panels, custom NGG assay design, and NGS for CE sequencing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eureka Genomics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for IQVIA
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to IQVIA
2.2 - Growth funds investing in similar companies to IQVIA
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for IQVIA
4.2 - Public trading comparable groups for IQVIA
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →